Interleukins represent a major category of cytokines, exerting core regulatory effects on immune balance and inflammatory responses. Initially identified in leukocytes, these bioactive molecules are now confirmed to be synthesized and secreted by multiple cell types, including macrophages and lymphocytes with complete structural integrity and biological functions. This review systematically summarizes key information related to interleukins, covering family classification and receptor distribution, classic signaling cascades, biological functions, as well as their regulatory roles in various inflammatory disorders.

Coagulation, or blood clotting, describes the process through which liquid blood transforms into a gel-like state to form a clot. This process is often referred to as secondary hemostasis, representing the second phase in stopping bleeding from damaged blood vessels. The first phase, primary hemostasis, involves vasoconstriction and platelet aggregation at the injury site. The coagulation mechanism relies on platelet activation, adhesion and aggregation, as well as fibrin deposition and maturation. Coagulation disorders can lead to excessive bleeding or pathological clot formation known as thrombosis.

Tumor markers (TM) are a series of substances produced by cancer cells or other cells that reflect tumor-related information. They play key roles in early cancer screening, auxiliary diagnosis, treatment efficacy evaluation, recurrence monitoring, and prognosis assessment. An ideal tumor marker features high specificity, strong sensitivity, stable properties, convenient detection, and close clinical relevance.

Our rigorous manufacturing processes and strict quality control protocols enable us to deliver ELISA kits with superior performance and consistent results for every assay you conduct. ExKits ELISA kits provide customers with the expected linearity range, linearity, Lower Limit of Detection, precision, recovery, stability, and natural sample detection capabilities, all backed by comprehensive validation testing. This testing covers multiple aspects, taking the Human IL-6 (Interleukin 6) ELISA Kit (XEH1100) as an example.

Inflammatory cytokines represent a category of bioactive regulatory molecules that modulate multiple inflammatory responses in organisms, generally divided into two major subgroups: pro‑inflammatory cytokines and anti‑inflammatory cytokines. A dynamic balance maintained between these two subgroups is essential for sustaining normal immune homeostasis and facilitating physiological tissue repair after damage.

In the fast-developing field of biomedical research, why does a technology with over 50 years of history like ELISA still hold a dominant position in immunoassays? Even with the continuous advancement of immunoassay technologies, ELISA remains the top choice for the reliable and accurate detection of proteins, antibodies, and hormones. But what makes ELISA the preferred method, even when newer technologies such as multiplex immunoassays offer the prospect of obtaining more data in a shorter time?

As a key tool, ELISA occupies a central position in various fields, such as basic scientific research, clinical diagnostics, environmental monitoring, and pharmaceutical development.